<PAGE> 1
-------------------------------
OMB APPROVAL
-------------------------------
OMB Number: 3235-0145
Expires: August 31, 1999
Estimated average burden
hours per response........14.90
-------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
UNITED DIAGNOSTIC, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
- --------------------------------------------------------------------------------
(Title of Class of Securities)
910192103
- --------------------------------------------------------------------------------
(CUSIP Number)
Craig Osborne, 10351 Santa Monica Blvd., Suite 101A, Los Angeles, CA 90025
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
December 31, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of SS.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box [ ].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See S.240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(continued on following pages)
(Page 1 of 4 Pages)
<PAGE> 2
CUSIP No. 910192103 SCHEDULE 13D Page 2 of 4 Pages
----------------- ---- ----
(1) Names of Reporting Persons
S.S. or I.R.S. Identification Nos. of Above Persons
Craig Osborne
---------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ X ]
---------------------------------------------------------------------
(3) SEC Use Only
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
PF
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
---------------------------------------------------------------------
(6) Citizenship or Place of Organization
USA
---------------------------------------------------------------------
(7) Sole Voting Power
Number of 89,963
Shares --------------------------------------------------------
Beneficially (8) Shared Voting Power
Owned by 0
Each --------------------------------------------------------
Reporting (9) Sole Dispositive Power
Person With 89,963
--------------------------------------------------------
(10) Shared Dispositive Power
0
--------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
89,963
---------------------------------------------------------------------
(12) Check Box if Aggregate Amount in Row (11) Excludes Certain
Shares* [ ]
---------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
19%
---------------------------------------------------------------------
(14) Type of Reporting Person*
IN
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE> 3
CUSIP No. 910192103 Page 3 of 4
SCHEDULE 13D
ITEM 1. SECURITY AND ISSUER
This statement relates to the Common Stock, par value $.01, of United
Diagnostic, Inc. (the "Common Stock"). The issuer's principal executive offices
are at 476 Main Street, Wakefield, Rhode Island 02879.
ITEM 2. IDENTITY AND BACKGROUND
(a) The person filing this statement (the "Filer") is Craig
Osborne, an individual.
(b) The Filer's business address is 10351 Santa Monica Boulevard,
Suite 101A, Los Angeles, California 90025.
(c) The Filer's present principal occupation or employment is with
In-House Attorney Service, located at 10351 Santa Monica
Boulevard, Suite 101A, Los Angeles, California 90025.
(d) The Filer has not during the last five years been convicted in
any criminal proceeding (excluding traffic violations or
similar misdemeanors).
(e) The Filer was not during the last five years a party to any
civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was
or is person subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or
finding any violation with respect to such laws.
(f) The Filer is a U.S. citizen.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The Filer purchased the securities, beneficial ownership of which is
being reported in this Schedule 13D, for an aggregate of $899.63. The source of
these funds was personal. The Filer did not borrow or otherwise obtain these
funds for the purpose of acquiring, holding, trading or voting the securities.
ITEM 4. PURPOSE OF TRANSACTION
The acquisition of securities to which this filing relates was made for
the Filer's personal investment.
<PAGE> 4
CUSIP No. 910192103 Page 4 of 4
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) The aggregate number of shares of Common Stock that the Filer
may be deemed to beneficially own is 89,963. Based on the
issuer's filings with the Securities and Exchange Commission,
such holdings in the aggregate constitute approximately 19% of
the outstanding shares of Common Stock.
(b) The Filer has sole power to vote or direct the vote, and sole
power to dispose or direct the disposition, of 100% of the
securities described in Item 5(a).
(c) During the 60 days immediately preceding the date of this
report, no transactions in Common Stock by the Filer took
place.
(d) The Filer does not know of any other person who has the right
to receive, or the power to direct the receipt of, dividends
from, or the proceeds from the sale of, shares of the Common
Stock to which this Schedule 13D relates.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDING OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER
The Filer has no contract, arrangement, understanding or relationship
(legal or otherwise) with any person with respect to any securities of the
issuer.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
None.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
5-5-99 /s/ CRAIG OSBORNE
- ----------------------- -----------------------
Date Signature
Craig Osborne
-----------------------
Name/Title
